FXH - First Trust Health Care AlphaDEX Fund (USD), US33734X1431 | Cbonds
ヒントモードがオンになっています オフ

FXH - First Trust Health Care AlphaDEX Fund (USD) (US33734X1431)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US33734X1431
FXH ISIN
上場投資信託(ETF)
ファンドのタイプ
First Trust
プロバイダー
127.63 USD
一口当たり純資産価値(NAV) | 2026/08/06
2007/05/08
設定日
4 年回
配当支払い
CEOJLS
CFI
FXH
ティッカー
Formed
ステータス
Equity
投資カテゴリー
Healthcare
セクター
USA
投資家所在地
StrataQuant(R) Health Care Index.
ベンチマーク
0.62 %
総保有コスト率(Total Cost Ratio)
1,078.48 百万 USD
ファンド基準価額 | 2026/08/06
1,078.48 百万 USD
株式クラス純資産価値(Share Class NAV) | 2026/08/06
いいえ
UCITS

利回り 時点 2026/08/06, NYSE Arca

  • 年初来
    -1.11 %
  • 1ヶ月
    -1.3 %
  • 3ヶ月
    -1.89 %
  • 6ヶ月
    1.42 %
  • 1年
    10.58 %
  • 3年
    8.75 %
  • 5年
    2.21 %
  • 10年
    101.62 %
「収入支払いを考慮した取引所価格で」

最新データ
比較する要素を追加

相場(FXH)

最も包括的なデータベースを探索

1 000 000

債券

100 000

175 910

ETF&投資信託

100 000

インデックス

最も効率的な方法でポートフォリオを追跡

  • 債券検索
  • ウォッチリスト
  • Excelアドイン

価格推移

FXH プロファイル

The First Trust Health Care AlphaDEX Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 08.05.2007 with unique ISIN - US33734X1431. Main exchange is NYSE Arca and ticker symbol is FXH. The total expense ratio is 0.62%. The First Trust Health Care AlphaDEX Fund (USD) pays dividends 4 time(s) per year.

構造 FXH 時点 2026/08/06

証券 価値
Regeneron Pharmaceuticals, Inc. 2.79%
Boston Scientific Corporation 2.6%
Universal Health Services, Inc. (Class B) 2.57%
Zimmer Biomet Holdings, Inc. 2.54%
Pfizer Inc. 2.45%
Solventum Corporation 2.42%
Guardant Health, Inc. 2.37%
Tenet Healthcare Corporation 2.31%
Globus Medical, Inc. (Class A) 2.31%
Centene Corporation 2.25%
The Cigna Group 2.25%
Natera, Inc. 2.2%
Corcept Therapeutics Inc. 2.09%
Encompass Health Corporation 2.08%
Medline Inc. (Class A) 1.97%
Axsome Therapeutics, Inc. 1.93%
ResMed Inc. 1.93%
Medtronic Plc 1.85%
Halozyme Therapeutics, Inc. 1.84%
DaVita Inc. 1.83%
Zoetis Inc. 1.81%
QIAGEN N.V. 1.8%
Arrowhead Pharmaceuticals, Inc. 1.77%
Incyte Corporation 1.76%
Elevance Health Inc. 1.7%
Eli Lilly and Company 1.67%
United Therapeutics Corporation 1.65%
Neurocrine Biosciences, Inc. 1.6%
Ascendis Pharma A/S 1.58%
Becton, Dickinson and Company 1.58%
Labcorp Holdings Inc. 1.53%
Quest Diagnostics Incorporated 1.52%
Bristol-Myers Squibb Company 1.5%
Medpace Holdings, Inc. 1.49%
Steris Plc 1.49%
GE HealthCare Technologies Inc. 1.48%
Revolution Medicines, Inc. 1.43%
Gilead Sciences, Inc. 1.4%
Viatris Inc. 1.39%
Doximity, Inc. (Class A) 1.35%
Exelixis, Inc. 1.3%
Biogen Inc. 1.29%
Veeva Systems Inc. (Class A) 1.03%
IQVIA Holdings Inc. 1.01%
Abbott Laboratories 1.%
Chemed Corporation 0.99%
Thermo Fisher Scientific Inc. 0.97%
BridgeBio Pharma, Inc. 0.94%
Ionis Pharmaceuticals, Inc. 0.93%
Agilent Technologies, Inc. 0.89%
Henry Schein, Inc. 0.89%
HCA Healthcare, Inc. 0.88%
Align Technology, Inc. 0.84%
Organon & Co. 0.84%
AbbVie Inc. 0.82%
Vertex Pharmaceuticals Incorporated 0.82%
Madrigal Pharmaceuticals, Inc. 0.8%
Tempus AI, Inc. (Class A) 0.67%
DexCom, Inc. 0.52%
Bio-Rad Laboratories, Inc. (Class A) 0.49%
The Ensign Group, Inc. 0.48%
Amgen Inc. 0.47%
IDEXX Laboratories, Inc. 0.47%
Illumina, Inc. 0.46%
BioMarin Pharmaceutical Inc. 0.45%
Stryker Corporation 0.45%
Danaher Corporation 0.44%
Envista Holdings Corporation 0.44%
Johnson & Johnson 0.43%
Revvity, Inc. 0.43%
The Cooper Companies, Inc. 0.43%
Merck & Co., Inc. 0.42%
West Pharmaceutical Services, Inc. 0.41%
US Dollar 0.21%
その他 - %

このプロバイダーのその他のETF&ファンド

類似のETF&ファンド

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    純資産価値(NAV)
    {{ item.expense_ratio }}
    総経費率(TER)
登録 is required アクセスを得るために必要です。